Diabetes and osteoporosis

Alois Saller, Stefania Maggi, Giovanna Romanato, Paolo Tonin, Gaetano Crepaldi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Care of patients with diabetes should include assessment of bone health. The extension of the average life expectancy of people with diabetes, which has accompanied improvements in medical care, has also increased the significance of osteoporosis. In addition to the usual causes of osteoporosis associated with aging, bone health is also compromised by diabetes. Studies on bone involvement in patients with diabetes mellitus have generated conflicting results, largely because of the pathogenetic complexity of the condition. It is now clear that patients with type 1 diabetes have lower bone mineral density (BMD) and a higher risk of fractures. Evidence is emerging that patients with type 2 diabetes who have complications are also at increased risk of certain types of osteoporotic fractures, despite having a higher BMD when compared to patients with type 1 diabetes. Although many factors, including number and type of falls, visual impairment, neuropathy, and reduced muscle strength, influence the probability of fractures, the most significant factor seems to be the strength of the bone itself. Thus, sarcopenia, a reduction in muscle mass and muscle strength, is considered one of the main determinants of bone fragility. The aim of this review is to examine the occurrence of osteoporosis in type 1 and type 2 diabetes.

Original languageEnglish
Pages (from-to)280-289
Number of pages10
JournalAging clinical and experimental research
Volume20
Issue number4
Publication statusPublished - Aug 2008

Fingerprint

Osteoporosis
Bone and Bones
Type 1 Diabetes Mellitus
Muscle Strength
Bone Density
Type 2 Diabetes Mellitus
Sarcopenia
Osteoporotic Fractures
Vision Disorders
Health
Life Expectancy
Patient Care
Diabetes Mellitus
Muscles

Keywords

  • Diabetes
  • Osteoporosis
  • Quality of bone
  • Sarcopenia

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

Saller, A., Maggi, S., Romanato, G., Tonin, P., & Crepaldi, G. (2008). Diabetes and osteoporosis. Aging clinical and experimental research, 20(4), 280-289.

Diabetes and osteoporosis. / Saller, Alois; Maggi, Stefania; Romanato, Giovanna; Tonin, Paolo; Crepaldi, Gaetano.

In: Aging clinical and experimental research, Vol. 20, No. 4, 08.2008, p. 280-289.

Research output: Contribution to journalArticle

Saller, A, Maggi, S, Romanato, G, Tonin, P & Crepaldi, G 2008, 'Diabetes and osteoporosis', Aging clinical and experimental research, vol. 20, no. 4, pp. 280-289.
Saller A, Maggi S, Romanato G, Tonin P, Crepaldi G. Diabetes and osteoporosis. Aging clinical and experimental research. 2008 Aug;20(4):280-289.
Saller, Alois ; Maggi, Stefania ; Romanato, Giovanna ; Tonin, Paolo ; Crepaldi, Gaetano. / Diabetes and osteoporosis. In: Aging clinical and experimental research. 2008 ; Vol. 20, No. 4. pp. 280-289.
@article{9e56c3dc5ca54ffa820b166dc51a2aae,
title = "Diabetes and osteoporosis",
abstract = "Care of patients with diabetes should include assessment of bone health. The extension of the average life expectancy of people with diabetes, which has accompanied improvements in medical care, has also increased the significance of osteoporosis. In addition to the usual causes of osteoporosis associated with aging, bone health is also compromised by diabetes. Studies on bone involvement in patients with diabetes mellitus have generated conflicting results, largely because of the pathogenetic complexity of the condition. It is now clear that patients with type 1 diabetes have lower bone mineral density (BMD) and a higher risk of fractures. Evidence is emerging that patients with type 2 diabetes who have complications are also at increased risk of certain types of osteoporotic fractures, despite having a higher BMD when compared to patients with type 1 diabetes. Although many factors, including number and type of falls, visual impairment, neuropathy, and reduced muscle strength, influence the probability of fractures, the most significant factor seems to be the strength of the bone itself. Thus, sarcopenia, a reduction in muscle mass and muscle strength, is considered one of the main determinants of bone fragility. The aim of this review is to examine the occurrence of osteoporosis in type 1 and type 2 diabetes.",
keywords = "Diabetes, Osteoporosis, Quality of bone, Sarcopenia",
author = "Alois Saller and Stefania Maggi and Giovanna Romanato and Paolo Tonin and Gaetano Crepaldi",
year = "2008",
month = "8",
language = "English",
volume = "20",
pages = "280--289",
journal = "Aging clinical and experimental research",
issn = "1594-0667",
publisher = "Springer International Publishing AG",
number = "4",

}

TY - JOUR

T1 - Diabetes and osteoporosis

AU - Saller, Alois

AU - Maggi, Stefania

AU - Romanato, Giovanna

AU - Tonin, Paolo

AU - Crepaldi, Gaetano

PY - 2008/8

Y1 - 2008/8

N2 - Care of patients with diabetes should include assessment of bone health. The extension of the average life expectancy of people with diabetes, which has accompanied improvements in medical care, has also increased the significance of osteoporosis. In addition to the usual causes of osteoporosis associated with aging, bone health is also compromised by diabetes. Studies on bone involvement in patients with diabetes mellitus have generated conflicting results, largely because of the pathogenetic complexity of the condition. It is now clear that patients with type 1 diabetes have lower bone mineral density (BMD) and a higher risk of fractures. Evidence is emerging that patients with type 2 diabetes who have complications are also at increased risk of certain types of osteoporotic fractures, despite having a higher BMD when compared to patients with type 1 diabetes. Although many factors, including number and type of falls, visual impairment, neuropathy, and reduced muscle strength, influence the probability of fractures, the most significant factor seems to be the strength of the bone itself. Thus, sarcopenia, a reduction in muscle mass and muscle strength, is considered one of the main determinants of bone fragility. The aim of this review is to examine the occurrence of osteoporosis in type 1 and type 2 diabetes.

AB - Care of patients with diabetes should include assessment of bone health. The extension of the average life expectancy of people with diabetes, which has accompanied improvements in medical care, has also increased the significance of osteoporosis. In addition to the usual causes of osteoporosis associated with aging, bone health is also compromised by diabetes. Studies on bone involvement in patients with diabetes mellitus have generated conflicting results, largely because of the pathogenetic complexity of the condition. It is now clear that patients with type 1 diabetes have lower bone mineral density (BMD) and a higher risk of fractures. Evidence is emerging that patients with type 2 diabetes who have complications are also at increased risk of certain types of osteoporotic fractures, despite having a higher BMD when compared to patients with type 1 diabetes. Although many factors, including number and type of falls, visual impairment, neuropathy, and reduced muscle strength, influence the probability of fractures, the most significant factor seems to be the strength of the bone itself. Thus, sarcopenia, a reduction in muscle mass and muscle strength, is considered one of the main determinants of bone fragility. The aim of this review is to examine the occurrence of osteoporosis in type 1 and type 2 diabetes.

KW - Diabetes

KW - Osteoporosis

KW - Quality of bone

KW - Sarcopenia

UR - http://www.scopus.com/inward/record.url?scp=56249107729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56249107729&partnerID=8YFLogxK

M3 - Article

C2 - 18852539

AN - SCOPUS:56249107729

VL - 20

SP - 280

EP - 289

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

IS - 4

ER -